These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 22508568

  • 1. Does Alzheimer's disease with early onset progress faster than with late onset? A case-control study of clinical progression and cerebrospinal fluid biomarkers.
    Grønning H, Rahmani A, Gyllenborg J, Dessau RB, Høgh P.
    Dement Geriatr Cogn Disord; 2012; 33(2-3):111-7. PubMed ID: 22508568
    [Abstract] [Full Text] [Related]

  • 2. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M, Vidal-Piñeiro D, Lladó A, Antonell A, Bosch B, Castellanos F, Bargalló N, Bartres-Faz D, Molinuevo JL, Sánchez-Valle R.
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [Abstract] [Full Text] [Related]

  • 3. A comparison of family history of psychiatric disorders among patients with early- and late-onset Alzheimer's disease.
    Devi G, Williamson J, Massoud F, Anderson K, Stern Y, Devanand DP, Mayeux R.
    J Neuropsychiatry Clin Neurosci; 2004; 16(1):57-62. PubMed ID: 14990760
    [Abstract] [Full Text] [Related]

  • 4. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [Abstract] [Full Text] [Related]

  • 5. Differences in routine clinical practice between early and late onset Alzheimer's disease: data from the Swedish Dementia Registry (SveDem).
    Eriksson H, Fereshtehnejad SM, Falahati F, Farahmand B, Religa D, Eriksdotter M.
    J Alzheimers Dis; 2014 Feb; 41(2):411-9. PubMed ID: 24614905
    [Abstract] [Full Text] [Related]

  • 6. Early-onset and late-onset Alzheimer's disease are associated with distinct patterns of memory impairment.
    Joubert S, Gour N, Guedj E, Didic M, Guériot C, Koric L, Ranjeva JP, Felician O, Guye M, Ceccaldi M.
    Cortex; 2016 Jan; 74():217-32. PubMed ID: 26694580
    [Abstract] [Full Text] [Related]

  • 7. Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease.
    Cho H, Jeon S, Kang SJ, Lee JM, Lee JH, Kim GH, Shin JS, Kim CH, Noh Y, Im K, Kim ST, Chin J, Seo SW, Na DL.
    Neurobiol Aging; 2013 Jul; 34(7):1921.e9-1921.e15. PubMed ID: 23391426
    [Abstract] [Full Text] [Related]

  • 8. The topography of grey matter involvement in early and late onset Alzheimer's disease.
    Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM.
    Brain; 2007 Mar; 130(Pt 3):720-30. PubMed ID: 17293358
    [Abstract] [Full Text] [Related]

  • 9. Could clinical profile influence CSF biomarkers in early-onset Alzheimer disease?
    Koric L, Felician O, Guedj E, Hubert AM, Mancini J, Boucraut J, Ceccaldi M.
    Alzheimer Dis Assoc Disord; 2010 Mar; 24(3):278-83. PubMed ID: 20473135
    [Abstract] [Full Text] [Related]

  • 10. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C, Bizzarro A, Daniele A, De Luca L, Ferraccioli M, Valenza A, Brahe C, Tiziano FD, Gainotti G, Masullo C.
    Dement Geriatr Cogn Disord; 2004 Mar; 18(2):125-31. PubMed ID: 15211066
    [Abstract] [Full Text] [Related]

  • 11. [The role of CSF markers in the early diagnosis of Alzheimer's disease].
    Vos SJ, Visser PJ, Verhey FR.
    Tijdschr Psychiatr; 2011 Mar; 53(9):647-53. PubMed ID: 21898322
    [Abstract] [Full Text] [Related]

  • 12. Relationship of amyloid-β burden with age-at-onset in Alzheimer disease.
    Choo IH, Lee DY, Kim JW, Seo EH, Lee DS, Kim YK, Kim SG, Park SY, Woo JI, Yoon EJ.
    Am J Geriatr Psychiatry; 2011 Jul; 19(7):627-34. PubMed ID: 21709608
    [Abstract] [Full Text] [Related]

  • 13. Caregiver burden and psychosocial services in patients with early and late onset Alzheimer's disease.
    Grønning H, Kristiansen S, Dyre D, Rahmani A, Gyllenborg J, Høgh P.
    Dan Med J; 2013 Jul; 60(7):A4649. PubMed ID: 23809965
    [Abstract] [Full Text] [Related]

  • 14. Changes in subcortical structures in early- versus late-onset Alzheimer's disease.
    Cho H, Seo SW, Kim JH, Kim C, Ye BS, Kim GH, Noh Y, Kim HJ, Yoon CW, Seong JK, Kim CH, Kang SJ, Chin J, Kim ST, Lee KH, Na DL.
    Neurobiol Aging; 2013 Jul; 34(7):1740-7. PubMed ID: 23394958
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population.
    Johansson P, Mattsson N, Hansson O, Wallin A, Johansson JO, Andreasson U, Zetterberg H, Blennow K, Svensson J.
    J Alzheimers Dis; 2011 Jul; 24(3):537-46. PubMed ID: 21297262
    [Abstract] [Full Text] [Related]

  • 18. Early-onset Alzheimer's disease: a global cross-sectional analysis.
    Panegyres PK, Chen HY, Coalition against Major Diseases (CAMD).
    Eur J Neurol; 2014 Sep; 21(9):1149-54, e64-5. PubMed ID: 24780092
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease.
    Blennow K, Zetterberg H, Rinne JO, Salloway S, Wei J, Black R, Grundman M, Liu E, AAB-001 201/202 Investigators.
    Arch Neurol; 2012 Aug; 69(8):1002-10. PubMed ID: 22473769
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.